Learn More
Description
Inhibits DNA synthesis by inhibiting the enzyme Topoisomerase II. Novobiocin Sodium Salt, MP Biomedicals is an antibiotic produced by Streptomyces nieveus. It is active against gram-positive bacteria. It is also a Hsp90 inhibitor 3.
Novobiocin inhibits DNA synthesis by inhibiting bacterial DNA gyrase targeting the GyrB subunit of the enzyme involved in energy transduction. It acts as a competitive inhibitor of the ATPase reaction catalysed by GyrB 2. Uses include:
- For the production of positively supercoiled plasmid DNA
- Inhibitor of bacterial DNA gyrase and eukaryotic DNA topoisomerase
- Inhibitor of retrovirus RNA-dependent DNA-polymerase
- To study heat shock protein inhibition
Specifications
Specifications
| Physical Form | Powder |
| Absorbance | λ max: 307nm |
| Melting Point | 220°C |
| Extinction Coefficient | E1%= 600 (0.1M NAOH) |
| Potency | ∼900μg/mg |
| Quantity | 25 g |
| Optical Rotation | −38.0° (2.5g/100ml ethanol at 24°C for the free acid) |
| Solubility Information | Freely soluble in water (10%, clear, colorless solution) |
| IUPAC Name | [(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate;molecular hydrogen;sodium |
| Formula Weight | 634.6 |
Safety and Handling
| Recommended Storage | Store at 2–8°C. |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.